Paula Zook, MD
Dermatology · Seattle, WANPI 1558321869
Payments from drug & device makers
Across 705 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Sanofi$1K
- Novartis$934
- Galderma Laboratories, L.p.$796
- Lilly USA, LLC$587
- plus $4K from 22 others
What the payments were for
- Food & beverage$11,58697%
- Education$4173%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 116 | $2,125 |
| Johnson & Johnson | 114 | $1,942 |
| Sanofi | 53 | $1,250 |
| Novartis | 64 | $934 |
| Galderma Laboratories, L.p. | 69 | $796 |
| Lilly USA, LLC | 29 | $587 |
| LEO Pharma Inc. | 31 | $464 |
| UCB, Inc. | 20 | $410 |
| Pfizer | 20 | $409 |
| E.r. Squibb & Sons, L.L.C. | 32 | $401 |
| Dermira, Inc. | 32 | $386 |
| Arcutis Biotherapeutics, Inc. | 23 | $345 |
| Sun Pharmaceutical Industries Inc. | 14 | $284 |
| Incyte Corporation | 11 | $266 |
| Regeneron Healthcare Solutions, Inc. | 9 | $266 |
| Mayne Pharma Commercial LLC | 16 | $221 |
| Dermavant Sciences, Inc. | 9 | $171 |
| Biofrontera Inc. | 8 | $120 |
| VYNE Pharmaceuticals Inc. | 10 | $119 |
| Amgen | 5 | $110 |
| Prugen, Inc. Pharmaceuticals | 5 | $89 |
| Almirall LLC | 4 | $79 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $79 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Strata Skin Sciences, Inc. | 2 | $36 |
| Sandoz | 1 | $25 |
| Organon | 2 | $24 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
How this compares
$12,003 in reported general payments places this provider in the 85th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $116,273 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $100,475 |
| Tacrolimus | 35 | $4,871 |
| Clobetasol Propionate | 147 | $3,539 |
| Fluorouracil | 19 | $1,460 |
| Ketoconazole | 75 | $1,158 |
| Tretinoin | 23 | $1,062 |
| ValacyclovirValacyclovir Hcl | 41 | $810 |
| Ciclopirox | 24 | $708 |
| Metronidazole | 22 | $648 |
| Mycophenolate Mofetil | 18 | $642 |
| Minoxidil | 67 | $575 |
| Econazole Nitrate | 20 | $501 |
| Hydroxychloroquine Sulfate | 24 | $493 |
| Fluocinonide | 14 | $453 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Seattle
- Vivian ShiSeattle$1.1M
- Michi ShinoharaSeattle$277K
- James CollyerSeattle$115K
- Alison YoungSeattle$53K
- Sonja KrejciSeattle$53K
- Paul NghiemSeattle$35K
- Andrew LinSeattle$19K
- John ScopettaSeattle$15K
- Tien NguyenSeattle$13K
- Cory SimpsonSeattle$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.